|
[2019 Oct;43(5)] Efficacy and Safety of Sodium-Glucose Cotransporter... |
2020-09-12 |
13,803 |
|
[2019 Oct;43(5)] Comparison of the Efficacy of Rosuvastatin Monother... |
2020-09-12 |
13,861 |
|
[2019 Oct;43(5)] Mitochondrial Toxins and Healthy Lifestyle Meet at ... |
2020-04-01 |
15,009 |
|
[2019 Oct;43(5)] Contributing Factors to Diabetic Brain Injury and C... |
2020-04-01 |
14,848 |
|
[2019 Oct;43(5)] Regulation of Systemic Glucose Homeostasis by T Hel... |
2020-01-17 |
15,439 |
|
Diabetes & Complicaion in Korea 2019 |
2019-10-22 |
9,327 |
|
[2019 Aug;43(4)] Glycosylated Hemoglobin in Subjects Affected by Iro... |
2019-10-10 |
18,326 |
|
[2019 Aug;43(4)] Impact of Longitudinal Changes in Metabolic Syndrom... |
2019-10-10 |
18,460 |
|
[2019 Aug;43(4)] Increased Serum Angiopoietin-Like 6 Ahead of Metabo... |
2019-10-10 |
18,255 |
|
[2019 Aug;43(4)] The Protective Effects of Increasing Serum Uric Aci... |
2019-10-10 |
18,220 |
|
[2019 Aug;43(4)] Factors Related to Blood Intact Incretin Levels in ... |
2019-10-10 |
216,195 |
|
[2019 Aug;43(4)] Diabetes Fact Sheets in Korea, 2018: An Appraisal o... |
2019-10-10 |
18,276 |
|
[2019 Aug;43(4)] Plasma Fetuin-A Levels and Risk of Type 2 Diabetes ... |
2019-10-10 |
18,224 |
|
[2019 Aug;43(4)] Lower Leg Fat Depots Are Associated with Albuminuri... |
2019-10-10 |
41,211 |
|
[2019 Aug;43(4)] Association between Serum Selenium Level and the Pr... |
2019-10-10 |
18,081 |
|
[2019 Aug;43(4)] Effectiveness and Safety of Adding Basal Insulin Gl... |
2019-10-10 |
18,098 |
|
[2019 Aug;43(4)] Additional Effect of Dietary Fiber in Patients with... |
2019-10-10 |
21,257 |
|
[2019 Aug;43(4)] Asian Subpopulations May Exhibit Greater Cardiovasc... |
2019-10-10 |
18,103 |
|
[2019 Aug;43(4)] 2019 Clinical Practice Guidelines for Type 2 Diabet... |
2019-10-10 |
18,781 |
|
[2019 Aug;43(4)] Continuous Glucose Monitoring Sensors for Diabetes ... |
2019-10-10 |
19,032 |
|
DIABETES FACT SHEET IN KOREA 2018 |
2018-10-10 |
11,141 |
46 |
[2014 Aug;38(4)] Clinical Usefulness of Serum Cystatin C as a Marker... |
2014-09-12 |
5,294 |
45 |
[2014 Aug;38(4)] A Novel Therapeutic Agent for Type 2 Diabetes Melli... |
2014-09-12 |
5,157 |
44 |
[2014 Aug;38(4)] Diabetic Kidney Disease: From Epidemiology to Clini... |
2014-09-12 |
4,827 |
43 |
[2014 Aug;38(4)] FGF21 as a Stress Hormone: The Roles of FGF21 in St... |
2014-09-12 |
4,847 |
42 |
[2014 Jun;38(3)] Current Status of Prescription in Type 2 Diabetic P... |
2014-07-23 |
5,166 |
41 |
[2014 Jun;38(3)] Factors Associated with Health-Related Quality of L... |
2014-07-23 |
5,405 |
40 |
[2014 Jun;38(3)] The Effect of DPP-4 Inhibitors on Metabolic Paramet... |
2014-07-23 |
5,273 |
39 |
[2014 Jun;38(3)] Efficacy of the Smartphone-Based Glucose Management... |
2014-07-23 |
4,856 |
38 |
[2014 Jun;38(3)] Current Status of Glycemic Control of Patients with... |
2014-07-23 |
5,412 |
37 |
[2014 Jun;38(3)] Journal Metrics-Based Position of Diabetes & Metabo... |
2014-07-23 |
4,906 |